These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7634619)

  • 1. Diagnosis of skeletal metastases and assessment of response to treatment.
    Galasko CS
    Clin Orthop Relat Res; 1995 Mar; (312):64-75. PubMed ID: 7634619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
    Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal metastases: an update of the literature with pictorial review.
    Zampakis P; Romanos O; Kraniotis P; Solomou EK
    J BUON; 2011; 16(1):24-37. PubMed ID: 21674846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
    Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
    Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN; Greene GS
    Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of primary skeletal neoplasms.
    Berquist TH
    Radiol Clin North Am; 1993 Mar; 31(2):411-24. PubMed ID: 8446757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Definition, diagnosis and treatment of prostatic carcinomas at an early stage].
    Akimoto S; Isaka S; Masai M; Shimazaki J
    Nihon Rinsho; 1989 May; 47(5):1178-84. PubMed ID: 2664275
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone metastases: new trends in diagnostic imaging].
    Herneth AM; Dominkus M; Kurtaran A; Lang S; Rand T; Kainberger F
    Wien Med Wochenschr Suppl; 2002; (113):92-4. PubMed ID: 12621852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic diseases and blastomas of the foot].
    Haller JF; Resnick D; Trattnig S; Breitenseher M; Hamed N; Giurea A; Imhof H
    Radiologe; 1995 Jul; 35(7):439-46. PubMed ID: 7676021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.
    Wittig JC; Bickels J; Priebat D; Jelinek J; Kellar-Graney K; Shmookler B; Malawer MM
    Am Fam Physician; 2002 Mar; 65(6):1123-32. PubMed ID: 11925089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
    Even-Sapir E
    J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers and skeletal metastases.
    Demers LM; Costa L; Lipton A
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S138-47. PubMed ID: 14600604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic imaging of skeletal metastases].
    Koizumi M; Koyama M
    Nihon Rinsho; 2006 Sep; 64(9):1731-7. PubMed ID: 16972688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumors of the musculoskeletal system.
    Vanel D; Verstraete KL; Shapeero LG
    Radiol Clin North Am; 1997 Jan; 35(1):213-37. PubMed ID: 8998216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically available evaluation of bone disease in breast cancer--validity and cost effectiveness.
    Coleman RE
    Can J Oncol; 1995 Dec; 5 Suppl 1():69-79. PubMed ID: 8853529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of bone turnover in prostate cancer.
    Garnero P
    Cancer Treat Rev; 2001 Jun; 27(3):187-92; discussion 193-6. PubMed ID: 11417970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases.
    Tombal B; Rezazadeh A; Therasse P; Van Cangh PJ; Vande Berg B; Lecouvet FE
    Prostate; 2005 Oct; 65(2):178-87. PubMed ID: 15948151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.